Cargando…

Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial

PURPOSE: We investigated whether age at anastrozole (A) initiation influences the effect of treatment on bone mineral density (BMD). We conducted a post hoc analysis of the dataset of Arimidex Bone Mass Index Oral Bisphosphonates prospective trial, studying the effect of risedronate (R) on BMD of po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markopoulos, Christos, Tzoracoleftherakis, Evagelos, Koukouras, Dimitrios, Venizelos, Basileios, Zobolas, Vasilios, Misitzis, John, Xepapadakis, Grigorios, Gogas, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418493/ https://www.ncbi.nlm.nih.gov/pubmed/22552718 http://dx.doi.org/10.1007/s00432-012-1233-z

Ejemplares similares

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial
por: Markopoulos, Christos, et al.
Publicado: (2010)

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy
por: Markopoulos, Christos, et al.
Publicado: (2009)

Plasma cell gingivitis - A rare case related to Colocasia (arbi) leaves
por: Bali, Deepika, et al.
Publicado: (2012)

Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial
por: Sestak, Ivana, et al.
Publicado: (2021)

Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
por: Bojanić, Kristina, et al.
Publicado: (2018)

Arbies et parameters pour la 3 ieme taunche: Acces operation normale + MD
por: Boillot, J
Publicado: (1983)

Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial
por: Goussia, Anna, et al.
Publicado: (2018)

Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
por: Markopoulos, Christos
Publicado: (2010)

The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer
por: Inoue, Hiroaki, et al.
Publicado: (2015)

Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon
por: Gogas, Helen, et al.
Publicado: (2010)

Genome Sequences of Arthrobacter sp. Phages Inspire2, Ronnie, Hunnie, DeWayne, CGermain, Copper, Azathoth, and Arby
por: Harrison, Melinda, et al.
Publicado: (2019)

Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy
por: Timotheadou, Eleni, et al.
Publicado: (2017)

Adjusting Breast Cancer Patient Prognosis with Non-HER2-Gene Patterns on Chromosome 17
por: Kotoula, Vassiliki, et al.
Publicado: (2014)

“Keeping the Boogie Man Away”: Medication Self-Management among Women Receiving Anastrozole Therapy
por: Wickersham, Karen, et al.
Publicado: (2012)

Effects of psoralen on the pharmacokinetics of anastrozole in rats
por: Zhang, Yuzhu, et al.
Publicado: (2018)

A New Mathematical Model for the Interpretation of Translational Research Evaluating Six CTLA-4 Polymorphisms in High-Risk Melanoma Patients Receiving Adjuvant Interferon
por: Pancoska, Petr, et al.
Publicado: (2014)

Anastrozole (Arimidex ™) – an aromatase inhibitor for the adjuvant setting?
por: Buzdar, A U
Publicado: (2001)

Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBI-TER 2
por: Taylor, Allen J, et al.
Publicado: (2007)

Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events
por: Kim, Yoo Jung, et al.
Publicado: (2020)

Glycogen-rich clear cell carcinoma of the breast
por: Markopoulos, Christos, et al.
Publicado: (2008)

Assessment of bone metabolism and biomechanical properties of the femur, following treatment with anastrozole and letrozole in an experimental model of menopause
por: Boutas, Ioannis, et al.
Publicado: (2017)

Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation
por: Regenthal, Ralf, et al.
Publicado: (2018)

Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole
por: Gorski, Justin Wayne, et al.
Publicado: (2017)

Response of Mouse Breast Cancer Cells to Anastrozole, Tamoxifen, and the Combination
por: Xanthopoulos, J. M., et al.
Publicado: (2005)

Anastrozole: Deep vein thrombosis and pulmonary embolism: case report
Publicado: (2021)

Escitalopram co-prescription in anastrozole-treated breast cancer patients
por: Ozyurt, Hazan, et al.
Publicado: (2022)

Anastrozole-related acute hepatitis with autoimmune features: a case report
por: Inno, Alessandro, et al.
Publicado: (2011)

Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy
por: GHIMENTI, CHIARA, et al.
Publicado: (2013)

A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
por: Aphinives, Potchavit, et al.
Publicado: (2015)

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
por: Monda, Vincenzo, et al.
Publicado: (2017)

Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women?
por: Gardella, Barbara, et al.
Publicado: (2021)

The efficacy of anastrozole in subfertile men with and without abnormal testosterone to estradiol ratios
por: Yang, Yang, et al.
Publicado: (2022)

Locomotion Outcome Improvement in Mice with Glioblastoma Multiforme after Treatment with Anastrozole
por: Aguilar-García, Irene Guadalupe, et al.
Publicado: (2023)

Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?
por: Oberguggenberger, A., et al.
Publicado: (2017)

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
por: Tsaousis, Georgios N., et al.
Publicado: (2019)

Anastrozole Improves Near Adult Height in Boys With Compromised Height Potential, as Monotherapy or in Combination With a GnRH Analogue
por: Papadimitriou, Dimitrios T, et al.
Publicado: (2021)

LBODP090 The Addition Of Anastrozole To Standard Testosterone Enanthate Treatment Significantly Improves Penile Size In Adolescent Boys With Micropenis
por: Papadimitriou, Dimitrios T, et al.
Publicado: (2022)

The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer
por: Dowsett, M, et al.
Publicado: (1999)

Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors
por: Eisner, Alvin, et al.
Publicado: (2007)

Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole – of clinical importance?
por: Geisler, J
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jbmu74op8a32fp83bkeakltdc8